William D. Waddill - 03 Jun 2024 Form 4 Insider Report for Turnstone Biologics Corp. (TSBX)

Reporting relationship: Director
Issuer ticker: TSBX
Reported as of: 03 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2024, 16:45:06 UTC
Prior SEC filing: 16 Apr 2024
Next SEC filing: 07 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Venkat Ramanan, Attorney-in-Fact

Key filing fact

William D. Waddill filed Form 4 for Turnstone Biologics Corp. (TSBX) on 02 Jul 2024.

Key facts

This page summarizes William D. Waddill's Form 4 filing for Turnstone Biologics Corp. (TSBX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2024, 16:45.

Change

Previous filing in this sequence was filed on 16 Apr 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TSBX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +12,770
Change %
Price: $0.000000
Shares after: 12,770
Date: 03 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,770
Exercise price: $2.69
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option will vest on the earlier of June 3, 2025 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.